Methods and compositions for the treatment of psychotic...

Details Methods and compositions for the treatment of psychotic... Methods and compositions for the treatment of psychotic...

2011-04-26

2011-04-26

Goldberg, Jeanine A (Department: 1634)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S091100, C435S091200, C536S023100, C536S024300

Reexamination Certificate

active

07932042

ABSTRACT:
Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a OPRP genetic signature are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the genetic signature.

REFERENCES:
patent: 6476208 (2002-11-01), Cohen et al.
patent: 6555316 (2003-04-01), Cohen et al.
patent: 7067627 (2006-06-01), Cohen et al.
patent: 7371811 (2008-05-01), Cohen et al.
patent: 7790396 (2010-09-01), Ramsey et al.
patent: 2003/0170667 (2003-09-01), Kaytes et al.
patent: 2003/0224365 (2003-12-01), Wood et al.
patent: 2004/0115699 (2004-06-01), Kaytes et al.
patent: 2005/0176057 (2005-08-01), Bremer et al.
patent: 2005/0260667 (2005-11-01), Cohen et al.
patent: 2006/0234223 (2006-10-01), Darvasi et al.
patent: 2007/0026402 (2007-02-01), Noble et al.
patent: 2007/0031853 (2007-02-01), Stanton, Jr. et al.
patent: 2007/0231801 (2007-10-01), Martucci et al.
patent: 2008/0182268 (2008-07-01), Cohen et al.
patent: 2008/0206768 (2008-08-01), Arranz
patent: 2009/0075827 (2009-03-01), Young et al.
patent: 2009/0281090 (2009-11-01), He et al.
patent: 2010/0105062 (2010-04-01), Brennan et al.
patent: 2010/0131432 (2010-05-01), Kennedy et al.
patent: 2010/0151461 (2010-06-01), Brennan
patent: WO 00/22122 (2000-04-01), None
patent: WO 00/50639 (2000-08-01), None
patent: WO 01/40493 (2001-06-01), None
patent: WO 02/086147 (2002-10-01), None
patent: WO 03/020980 (2003-03-01), None
patent: WO 03/101377 (2003-12-01), None
patent: WO 2004/020580 (2004-03-01), None
patent: WO 2005/007871 (2005-01-01), None
patent: WO 2005/118848 (2005-12-01), None
patent: WO 2008/076449 (2008-06-01), None
patent: WO 2008/086579 (2008-07-01), None
patent: WO 2009/082743 (2009-07-01), None
patent: WO 2009/089120 (2009-07-01), None
patent: WO 2009/092032 (2009-07-01), None
patent: WO 2010/036353 (2010-04-01), None
Sullivan et al. “Genomewide assocation for schizophrenia in the CATIE study: results of stage 1” Molecular Psychiatry, vol. 13, pp. 570-584, 2008.
Mudge et al., “Genomic convergence analysis of Schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum,”PLoS ONE, 3:e3625, 2008.
Reference SNP(refSNP) Cluster Report: rs7975477, Entrez SNP, Dec. 30, 2008, Retrieved from the internet, http://www.ncbi.nlm.nih.gov/projects/SNP/snp—ref.cgi?rs=7975477, Sep. 15, 2010.
Reference SNP(refSNP) Cluster Report: rs11960832, Entrez SNP, Dec. 30, 2008, Retrieved from the internet, http://www.ncbi.nlm.nih.gov/projects/SNP/snp—ref.cgi?rs=11960832, Sep. 15, 2010.

Affiliated with

Also associated with

Rating

Methods and compositions for the treatment of psychotic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for the treatment of psychotic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for the treatment of psychotic... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2704546